XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Commitments and Contingencies (Tables)
 9 Months Ended
Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments

The Company is committed to lease payments as follows:

 

Fiscal year ending September 30,        
2017     $ 28,047  
2018       112,189  
2019       56,094  
      $ 196,330  
Schedule of purchase warrants outstanding

 

A summary of the status of Company’s outstanding share purchase warrants is presented below:

  

      Number of Shares     Weighted Average Exercise Price  
Balance, October 1, 2015       4,272,890     $ 2.11  
Exercised       (2,463,581 )   $ 1.67  
Balance, September 30, 2016       1,809,309     $ 2.70  
Exercised       (200,000 )   $ 3.00  
Balance,June 30, 2017       1,609,309     $ 2.66  
Schedule of exercisable share purchase warrants outstanding

At June 30, 2017, the Company had share purchase warrants outstanding of 1,609,309, with a weighted average exercise price of $2.66 as follows:

 

Number     Exercise Price     Expiry Date
  1,262,180     $ 3.00     July 5, 2018
  30,000     $ 4.00     February 24, 2019
  277,127     $ 1.20     March 13, 2019
  1,252     $ 1.68     March 13, 2019
  31,250     $ 1.24     May 31, 2019
  7,500     $ 1.04     May 31, 2019
  1,609,309              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

 

      Number of Shares     Weighted Average
Exercise Price		     Weighted Average
Grant Date fair value		  
Outstanding at October 1, 2015       1,822,500     $ 2.00          
Granted       2,401,500     $ 5.22     $ 4.38  
Expired       (25,000 )   $ 14.68          
Outstanding at September 30, 2016       4,199,000     $ 3.76          
Granted       1,080,000     $ 5.55     $ 5.48  
Forfeited       (141,345 )   $ 4.02          
Outstanding at June 30, 2017       5,137,655     $ 4.13          
Exercisable at June 30, 2017       3,124,885     $ 2.89          
Exercisable at September 30, 2016       2,290,717     $ 2.41          
Schedule of stock options outstanding

At June 30, 2017, the following stock options were outstanding:

 

Number of Shares           Aggregate   Remaining  
    Number   Exercise       Intrinsic   Contractual  
Total   Vested   Price   Expiry Date   Value   Life (yrs)  
  500,000     500,000   $ 1.60   July 5, 2023   $ 1,860,000     6.01  
  75,000     75,000   $ 1.20   May 7, 2024     309,000     6.85  
  125,000     93,750   $ 1.32   May 8, 2024     500,000     6.86  
  718,750     718,750   $ 0.92   April 2, 2025     3,162,500     7.76  
  29,167     29,167   $ 1.44   June 8, 2025     113,168     7.94  
  50,000     33,333   $ 1.76   June 15, 2025     178,000     7.96  
  273,542     177,500   $ 5.04   September 18, 2025     76,592     8.22  
  1,500     1,500   $ 5.64   September 30, 2025     —     8.25  
  31,250     18,230   $ 5.68   October 2, 2025     —     8.26  
  25,000     14,583   $ 8.98   October 16, 2025     —     8.30  
  1,500     1,500   $ 5.57   December 31, 2025     —     8.50  
  1,500     1,500   $ 4.90   March 31, 2026     630     8.75  
  1,500     1,500   $ 5.66   April 27, 2026     —     8.82  
  19,697     19,697   $ 4.09   May 18, 2026     24,227     8.88  
  1,500     1,500   $ 6.11   June 30, 2026     —     9.00  
  379,625     94,906   $ 6.26   July 5, 2026     —     9.01  
  861,429     215,357   $ 7.06   July 18, 2026     —     9.05  
  40,000     13,333   $ 3.06   September 7, 2026     90,400     9.19  
  1,006,696     1,006,696   $ 3.28   September 22, 2026     2,053,660     9.23  
  89,999     29,999   $ 3.63   October 3, 2026     152,098     9.26  
  15,000     3,750   $ 4.35   December 9, 2026     14,550     9.44  
  50,000     —   $ 5.39   February 7, 2027     —     9.61  
  40,000     6,666   $ 5.26   February 17, 2027     2,400     9.63  
  800,000     66,668   $ 5.92   May 12, 2027     —     9.86  
  5,137,655     3,124,885             $ 8,537,225        
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

 

  Three months ended June 30,   Nine months ended June 30,  
  2017   2016   2017   2016  
General and administrative $ 574,470   $ 127,473   $ 1,452,181   $ 715,991  
Research and development   585,246     102,766     1,565,695     560,976  
Total share based compensation $ 1,159,716   $ 230,239   $ 3,017,876   $ 1,276,967  
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

  

  2017   2016  
Risk-free interest rate   1.98 %   1.67 %
Expected life of options (years)   6.82     6.63  
Annualized volatility   111.67 %   105.21 %
Dividend rate   0.00 %   0.00 %